Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial

INTRODUCTION: Status migrainosus is a disabling complication of migraine, which frequently results in hospitalisation. For patients who fail to respond to simple analgesia, triptans and intravenous prochlorperazine or chlorpromazine, there are limited treatment options, and a paucity of high-quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Jason Charles, Chen, Zhibin, Ramsay, Georgia, Germaine, Jack, Hutton, Elspeth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905943/
https://www.ncbi.nlm.nih.gov/pubmed/35260463
http://dx.doi.org/10.1136/bmjopen-2021-059647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905943/
https://www.ncbi.nlm.nih.gov/pubmed/35260463
http://dx.doi.org/10.1136/bmjopen-2021-059647

Ejemplares similares